COVID-19: Vaccines and Therapeutics
The federal government has agreed to purchase at least 100,000 doses of the combination monoclonal antibody therapy bamlanivimab and etesevimab, Eli Lilly and Company announced.
The Food and Drug Administration granted an emergency use authorization for Johnson & Johnson’s single-dose COVID-19 vaccine.
A summary of important information for providers on Johnson & Johnson’s COVID-19 vaccine.
The House of Representatives early this morning voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide reconciliation protection for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and…
- Novel Coronavirus (SARS-CoV-2/COVID-19)
- Legislation and Legislative Advocacy
- Advocacy & Public Policy
- COVID-19: Vaccines and Therapeutics
- Medicaid
- Marketplace Issues/Stability
- Medicare DSH
- Substance Use Disorder
- Behavioral Health Intervention & Issues Prevention
- Workforce
- Skilled Nursing Facility PPS
- OSHA
- Rural issues
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee recommended the approval of Johnson & Johnson’s COVID-19 vaccine candidate.
Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released by the Centers for Disease Control and Prevention.
AHA released a one-stop web hub for hospitals and health systems to find communication resources related to COVID-19 vaccines.
The Food and Drug Administration will allow undiluted frozen vials of the Pfizer COVID-19 vaccine to be transported and stored at conventional pharmaceutical freezer temperatures (-13°F to 5°F) for up to two weeks as an alternative to its preferred storage at -112 F to -76ºF, the agency announced…
The Food and Drug Administration's Office of Minority Health and Health Equity released two videos on COVID-19 vaccines and the importance of communities of color who have been disproportionately impacted by COVID-19 getting vaccinated to protect themselves and loved ones from the virus.
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines, and help train current and future health care personnel to prevent and control infectious disease.